Artelo Biosciences OverviewArtelo Biosciences EBIT
EBIT (Earnings Before Interest and Taxes) analysis for ARTL.
Quarterly EBIT
-$2.83M
↓ 19.13% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$12.78M
↓ 29.13% YoY
Trailing 12 months ending Mar 31, 2026
Artelo Biosciences OverviewEBIT (Earnings Before Interest and Taxes) analysis for ARTL.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026